| E-Mindfulness Approaches for Living After Breast Cancer | Phase 3 | NRG Oncology | <1 mi |
| The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic | N/A | Children's National Research Institute | <1 mi |
| Mindful Self-Compassion for Anxiety Disorders and Depression | N/A | Georgetown University | <1 mi |
| Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method | N/A | Georgetown University | <1 mi |
| Does Social Media Impact Adolescent Mental Health? | N/A | Georgetown University | <1 mi |
| Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes | N/A | Children's National Research Institute | <1 mi |
| CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms | N/A | Johns Hopkins University | 6 mi |
| Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression | Phase 1 | National Institute of Mental Health (NIMH) | 6 mi |
| Long-term Observation of Participants With Mood Disorders | — | National Institute of Mental Health (NIMH) | 6 mi |
| Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder | Phase 1 | National Institute of Mental Health (NIMH) | 6 mi |
| Natural History of Depression, Bipolar Disorder and Suicide Risk | — | National Institute of Mental Health (NIMH) | 6 mi |
| PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD) | Phase 1 | National Institute of Mental Health (NIMH) | 6 mi |
| Neurobiology of Suicide | Phase 2 | National Institute of Mental Health (NIMH) | 6 mi |
| [18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET | Phase 1 | National Institute of Mental Health (NIMH) | 6 mi |
| Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD) | N/A | National Institute of Mental Health (NIMH) | 6 mi |
| Characterization and Treatment of Adolescent Depression | — | National Institute of Mental Health (NIMH) | 6 mi |
| Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression | Phase 2 | National Institute of Mental Health (NIMH) | 6 mi |
| NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder | — | National Institute of Mental Health (NIMH) | 6 mi |
| Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders | Phase 2 | National Institute of Mental Health (NIMH) | 6 mi |
| Evaluation of the Genetics of Bipolar Disorder | — | National Institute of Mental Health (NIMH) | 6 mi |
| Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers | — | National Institute of Mental Health (NIMH) | 6 mi |
| Clinical Validation of a Predictive Test for Postpartum Depression | — | University of Virginia | 7 mi |
| Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication | N/A | University of Maryland, College Park | 7 mi |
| Clinical Trial on Agitation in Alzheimer's Dementia | Phase 2 | IGC Pharma, LLC | 12 mi |
| Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer | Phase 2 | Sunstone Medical | 14 mi |
| A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) | Phase 2 | atai Therapeutics, Inc. | 14 mi |
| "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" | Phase 3 | Cybin IRL Limited | 14 mi |
| Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) | Phase 3 | Cybin IRL Limited | 14 mi |
| GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia | Phase 2 | Syndeio Biosciences, Inc | 14 mi |
| RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses | Phase 2 | Reunion Neuroscience Inc | 14 mi |
| rTMS for Military TBI-related Depression | N/A | Henry M. Jackson Foundation for the Advancement of Military Medicine | 15 mi |
| Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY) | Phase 2 | Autobahn Therapeutics, Inc. | 15 mi |
| A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder | Phase 2 | Janssen Research & Development, LLC | 19 mi |
| A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression | Phase 2 | Draig Therapeutics Ltd | 19 mi |
| NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) | Phase 3 | Neurocrine Biosciences | 19 mi |
| ALTO-100 in Bipolar Disorder With Depression (BD-D) | Phase 2 | Alto Neuroscience | 19 mi |
| Advanced Prediction of Respiratory Depression Episode With the Linshom Continuous Predictive Respiratory Sensor | — | Linshom Medical, Inc. | 28 mi |
| A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression | N/A | LivaNova | 28 mi |
| A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge) | Phase 3 | Definium Therapeutics US, Inc. | 35 mi |
| Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder | Phase 3 | Neumora Therapeutics, Inc. | 35 mi |
| CAPABLE Transplant | N/A | Johns Hopkins University | 35 mi |
| Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder | Phase 4 | Johns Hopkins University | 35 mi |
| Glucose Variability and Cognition in Prediabetes | — | University of Maryland, Baltimore | 35 mi |
| Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor | — | Linshom Medical, Inc. | 35 mi |
| Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study | N/A | Johns Hopkins University | 35 mi |
| Identification and Validation of Epigenetic Biomarkers of PMDD | — | Johns Hopkins University | 35 mi |
| Preventing Postpartum Depression in Immigrant Latinas | N/A | Northwestern University | 35 mi |
| A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. | Phase 3 | AbbVie | 35 mi |
| Study to Assess the Safety and Effectiveness of NMRA-335140-501 | Phase 3 | Neumora Therapeutics, Inc. | 35 mi |
| A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) | Phase 3 | Xenon Pharmaceuticals Inc. | 35 mi |
| Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients | Phase 3 | Intra-Cellular Therapies, Inc. | 35 mi |
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | Phase 3 | Cybin IRL Limited | 35 mi |
| Psilocybin in Chronic Low Back Pain and Depression | Phase 1 | Johns Hopkins University | 35 mi |
| Defining Neurobiological Links Between Substance Use and Mental Illness | N/A | National Institute on Drug Abuse (NIDA) | 35 mi |
| Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease | Early 1 | Johns Hopkins University | 35 mi |
| Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention | N/A | Johns Hopkins Bloomberg School of Public Health | 35 mi |
| VR-PMR for Post-Burn Symptoms | N/A | Johns Hopkins University | 35 mi |
| Whole Health in VA Mental Health: Omnis Salutis | N/A | VA Office of Research and Development | 35 mi |